BRAINSTORM CELL THERAPEUTICS INC. Net Income
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Net Income of -$3.85 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-14
- BRAINSTORM CELL THERAPEUTICS INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$3.85M.
- BRAINSTORM CELL THERAPEUTICS INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$2.13M.
- BRAINSTORM CELL THERAPEUTICS INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$2.43M.
- BRAINSTORM CELL THERAPEUTICS INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$2.11M.
- BRAINSTORM CELL THERAPEUTICS INC. net income (loss) attributable to parent for fiscal 2025 was -$10.31M.
- BRAINSTORM CELL THERAPEUTICS INC. net income (loss) attributable to parent for fiscal 2024 was -$11.62M.
- BRAINSTORM CELL THERAPEUTICS INC. net income (loss) attributable to parent for fiscal 2023 was -$17.19M.
- BRAINSTORM CELL THERAPEUTICS INC. net income (loss) attributable to parent for fiscal 2022 was -$24.28M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 129 month | Net Income (Loss) Attributable to Parent 132 month | Net Income (Loss) Attributable to Parent 135 month | Net Income (Loss) Attributable to Parent 138 month | Net Income (Loss) Attributable to Parent 141 month | Net Income (Loss) Attributable to Parent 144 month | Net Income (Loss) Attributable to Parent 147 month | Net Income (Loss) Attributable to Parent 150 month | Net Income (Loss) Attributable to Parent 153 month | Net Income (Loss) Attributable to Parent 156 month | Net Income (Loss) Attributable to Parent 159 month | Net Income (Loss) Attributable to Parent 162 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.85M 10-Q · filed 2026-08-14 | -$5.98M 10-Q · filed 2026-08-14 | -$8.42M derived: sum of 3 quarters · filed 2026-08-14 | -$10.52M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||||
| 2026-03-31 | -$2.13M 10-Q · filed 2026-08-14 | -$4.56M derived: sum of 2 quarters · filed 2026-08-14 | -$6.67M derived: sum of 3 quarters · filed 2026-08-14 | -$9.57M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||||
| 2025-12-31 | -$2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$4.54M derived: sum of 2 quarters · filed 2026-03-31 | -$7.44M derived: sum of 3 quarters · filed 2026-08-14 | -$10.31M 10-K · filed 2026-03-31 | |||||||||||||||
| 2025-09-30 | -$2.11M 10-Q · filed 2025-11-14 | -$5.01M derived: sum of 2 quarters · filed 2026-08-14 | -$7.87M 10-Q · filed 2025-11-14 | -$10.85M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||||
| 2025-06-30 | -$2.90M 10-Q · filed 2026-08-14 | -$5.77M 10-Q · filed 2026-08-14 | -$8.74M derived: sum of 3 quarters · filed 2026-08-14 | -$11.45M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||||
| 2025-03-31 | -$2.86M 10-Q · filed 2026-08-14 | -$5.84M derived: sum of 2 quarters · filed 2026-08-14 | -$8.54M derived: sum of 3 quarters · filed 2026-08-14 | -$11.09M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||||
| 2024-12-31 | -$2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$5.68M derived: sum of 2 quarters · filed 2026-03-31 | -$8.22M derived: sum of 3 quarters · filed 2026-03-31 | -$11.62M 10-K · filed 2026-03-31 | |||||||||||||||
| 2024-09-30 | -$2.71M 10-Q · filed 2025-11-14 | -$5.25M derived: sum of 2 quarters · filed 2025-11-14 | -$8.65M 10-Q · filed 2025-11-14 | -$14.23M derived: sum of 4 quarters · filed 2025-11-14 | |||||||||||||||
| 2024-06-30 | -$2.54M 10-Q · filed 2025-11-14 | -$5.94M 10-Q · filed 2025-08-14 | -$11.52M derived: sum of 3 quarters · filed 2025-11-14 | -$12.75M derived: sum of 4 quarters · filed 2025-11-14 | |||||||||||||||
| 2024-03-31 | -$3.40M 10-Q · filed 2025-11-14 | -$8.98M derived: sum of 2 quarters · filed 2025-11-14 | -$10.21M derived: sum of 3 quarters · filed 2025-11-14 | -$15.53M derived: sum of 4 quarters · filed 2025-11-14 | |||||||||||||||
| 2023-12-31 | -$5.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$6.80M derived: sum of 2 quarters · filed 2025-03-31 | -$12.13M derived: sum of 3 quarters · filed 2025-03-31 | -$17.19M 10-K · filed 2025-03-31 | |||||||||||||||
| 2023-09-30 | -$1.23M 10-Q · filed 2024-11-14 | -$6.55M derived: sum of 2 quarters · filed 2024-11-14 | -$11.61M 10-Q · filed 2024-11-14 | -$16.63M derived: sum of 4 quarters · filed 2024-11-14 | |||||||||||||||
| 2023-06-30 | -$5.33M 10-Q · filed 2024-11-14 | -$10.39M 10-Q · filed 2024-08-14 | -$15.41M derived: sum of 3 quarters · filed 2024-11-14 | -$22.26M derived: sum of 4 quarters · filed 2024-11-14 | |||||||||||||||
| 2023-03-31 | -$5.06M 10-Q · filed 2024-11-14 | -$10.08M derived: sum of 2 quarters · filed 2024-11-14 | -$16.93M derived: sum of 3 quarters · filed 2024-11-14 | -$23.98M derived: sum of 4 quarters · filed 2024-11-14 | |||||||||||||||
| 2022-12-31 | -$5.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$11.88M derived: sum of 2 quarters · filed 2024-04-01 | -$18.92M derived: sum of 3 quarters · filed 2024-04-01 | -$24.28M 10-K · filed 2024-04-01 | |||||||||||||||
| 2022-09-30 | -$6.86M 10-Q · filed 2023-11-14 | -$13.90M derived: sum of 2 quarters · filed 2023-11-14 | -$19.26M 10-Q · filed 2023-11-14 | -$25.45M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||||||
| 2022-06-30 | -$7.04M 10-Q · filed 2023-11-14 | -$12.40M 10-Q · filed 2023-08-14 | -$18.59M derived: sum of 3 quarters · filed 2023-11-14 | -$23.93M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||||||
| 2022-03-31 | -$5.36M 10-Q · filed 2023-11-14 | -$11.55M derived: sum of 2 quarters · filed 2023-11-14 | -$16.89M derived: sum of 3 quarters · filed 2023-11-14 | -$23.16M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||||||
| 2021-12-31 | -$6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$11.53M derived: sum of 2 quarters · filed 2023-03-30 | -$17.80M derived: sum of 3 quarters · filed 2023-03-30 | -$24.46M 10-K · filed 2023-03-30 | |||||||||||||||
| 2021-09-30 | -$5.34M 10-Q · filed 2022-11-14 | -$11.61M derived: sum of 2 quarters · filed 2022-11-14 | -$18.27M 10-Q · filed 2022-11-14 | -$30.08M derived: sum of 4 quarters · filed 2022-11-14 | |||||||||||||||
| 2021-06-30 | -$6.27M 10-Q · filed 2022-11-14 | -$12.93M 10-Q · filed 2022-08-15 | -$24.75M derived: sum of 3 quarters · filed 2022-11-14 | -$29.23M derived: sum of 4 quarters · filed 2022-11-14 | |||||||||||||||
| 2021-03-31 | -$6.66M 10-Q · filed 2022-11-14 | -$18.48M derived: sum of 2 quarters · filed 2022-11-14 | -$22.96M derived: sum of 3 quarters · filed 2022-11-14 | -$30.36M derived: sum of 4 quarters · filed 2022-11-14 | |||||||||||||||
| 2020-12-31 | -$11.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$16.30M derived: sum of 2 quarters · filed 2022-03-28 | -$23.70M derived: sum of 3 quarters · filed 2022-03-28 | -$31.81M 10-K · filed 2022-03-28 | |||||||||||||||
| 2020-09-30 | -$4.49M 10-Q · filed 2021-11-15 | -$11.88M derived: sum of 2 quarters · filed 2021-11-15 | -$20.00M 10-Q · filed 2021-11-15 | -$27.69M derived: sum of 4 quarters · filed 2021-11-15 | |||||||||||||||
| 2020-06-30 | -$7.39M 10-Q · filed 2021-11-15 | -$15.51M 10-Q · filed 2021-08-05 | -$23.20M derived: sum of 3 quarters · filed 2021-11-15 | -$28.83M derived: sum of 4 quarters · filed 2021-11-15 | |||||||||||||||
| 2020-03-31 | -$8.11M 10-Q · filed 2021-11-15 | -$15.81M derived: sum of 2 quarters · filed 2021-11-15 | -$21.44M derived: sum of 3 quarters · filed 2021-11-15 | -$26.34M derived: sum of 4 quarters · filed 2021-11-15 | |||||||||||||||
| 2019-12-31 | -$7.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-04 | -$13.33M derived: sum of 2 quarters · filed 2021-02-04 | -$18.23M derived: sum of 3 quarters · filed 2021-02-04 | -$23.25M 10-K · filed 2021-02-04 | |||||||||||||||
| 2019-09-30 | -$5.63M 10-Q · filed 2020-10-15 | -$10.53M derived: sum of 2 quarters · filed 2020-10-15 | -$15.56M 10-Q · filed 2020-10-15 | -$20.94M derived: sum of 4 quarters · filed 2020-10-15 | |||||||||||||||
| 2019-06-30 | -$4.90M 10-Q · filed 2020-10-15 | -$9.93M 10-Q · filed 2020-08-05 | -$15.31M derived: sum of 3 quarters · filed 2020-10-15 | -$18.49M derived: sum of 4 quarters · filed 2020-10-15 | |||||||||||||||
| 2019-03-31 | -$5.03M 10-Q · filed 2020-10-15 | -$10.41M derived: sum of 2 quarters · filed 2020-10-15 | -$13.59M derived: sum of 3 quarters · filed 2020-10-15 | -$16.68M derived: sum of 4 quarters · filed 2020-10-15 | |||||||||||||||
| 2018-12-31 | -$5.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$8.56M derived: sum of 2 quarters · filed 2020-02-18 | -$11.65M derived: sum of 3 quarters · filed 2020-02-18 | -$13.95M 10-K · filed 2020-02-18 | |||||||||||||||
| 2018-09-30 | -$3.18M 10-Q · filed 2019-11-14 | -$6.27M derived: sum of 2 quarters · filed 2019-11-14 | -$8.56M 10-Q · filed 2019-11-14 | -$8.29M derived: sum of 4 quarters · filed 2019-11-14 | |||||||||||||||
| 2018-06-30 | -$3.09M 10-Q · filed 2019-08-13 | -$5.39M 10-Q · filed 2019-08-13 | -$5.11M derived: sum of 3 quarters · filed 2019-08-13 | -$7.52M derived: sum of 4 quarters · filed 2019-08-13 | |||||||||||||||
| 2018-03-31 | -$2.30M 10-Q · filed 2019-05-10 | -$2.02M derived: sum of 2 quarters · filed 2019-05-10 | -$4.42M derived: sum of 3 quarters · filed 2019-05-10 | -$5.46M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||||||||
| 2017-12-31 | $276.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$2.13M derived: sum of 2 quarters · filed 2019-04-01 | -$3.17M derived: sum of 3 quarters · filed 2019-04-01 | -$4.95M 10-K · filed 2019-04-01 | |||||||||||||||
| 2017-09-30 | -$2.40M 10-Q · filed 2018-10-29 | -$3.44M derived: sum of 2 quarters · filed 2018-10-29 | -$5.23M 10-Q · filed 2018-10-29 | -$5.85M derived: sum of 4 quarters · filed 2018-10-29 | |||||||||||||||
| 2017-06-30 | -$1.04M 10-Q · filed 2018-07-23 | -$2.83M 10-Q · filed 2018-07-23 | -$3.45M derived: sum of 3 quarters · filed 2018-07-23 | -$5.05M derived: sum of 4 quarters · filed 2018-07-23 | |||||||||||||||
| 2017-03-31 | -$1.78M 10-Q · filed 2018-05-14 | -$2.41M derived: sum of 2 quarters · filed 2018-05-14 | -$4.01M derived: sum of 3 quarters · filed 2018-05-14 | -$4.98M derived: sum of 4 quarters · filed 2018-05-14 | |||||||||||||||
| 2016-12-31 | -$624.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$2.23M derived: sum of 2 quarters · filed 2018-03-08 | -$3.19M derived: sum of 3 quarters · filed 2018-03-08 | -$4.98M 10-K · filed 2018-03-08 | |||||||||||||||
| 2016-09-30 | -$1.61M 10-Q · filed 2017-10-17 | -$2.57M derived: sum of 2 quarters · filed 2017-10-17 | -$4.36M 10-Q · filed 2017-10-17 | -$5.74M derived: sum of 4 quarters · filed 2017-10-17 | |||||||||||||||
| 2016-06-30 | -$962.00K 10-Q · filed 2017-08-14 | -$2.75M 10-Q · filed 2017-08-14 | -$4.14M derived: sum of 3 quarters · filed 2017-08-14 | -$6.74M derived: sum of 4 quarters · filed 2017-08-14 | |||||||||||||||
| 2016-03-31 | -$1.79M 10-Q · filed 2017-05-15 | -$3.17M derived: sum of 2 quarters · filed 2017-05-15 | -$5.78M derived: sum of 3 quarters · filed 2017-05-15 | -$8.04M derived: sum of 4 quarters · filed 2017-05-15 | |||||||||||||||
| 2015-12-31 | -$1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | -$3.99M derived: sum of 2 quarters · filed 2017-03-29 | -$6.25M derived: sum of 3 quarters · filed 2017-03-29 | -$8.49M 10-K · filed 2017-03-29 | |||||||||||||||
| 2015-09-30 | -$2.60M 10-Q · filed 2016-11-14 | -$4.87M derived: sum of 2 quarters · filed 2016-11-14 | -$7.10M 10-Q · filed 2016-11-14 | -$9.83M derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||||||
| 2015-06-30 | -$2.27M 10-Q · filed 2016-08-11 | -$4.50M 10-Q · filed 2016-08-11 | -$7.23M derived: sum of 3 quarters · filed 2016-08-11 | -$9.65M derived: sum of 4 quarters · filed 2016-08-11 | |||||||||||||||
| 2015-03-31 | -$2.24M 10-Q · filed 2016-05-10 | -$4.97M derived: sum of 2 quarters · filed 2016-05-10 | -$7.39M derived: sum of 3 quarters · filed 2016-05-10 | -$9.37M derived: sum of 4 quarters · filed 2016-05-10 | |||||||||||||||
| 2014-12-31 | -$2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | -$5.15M derived: sum of 2 quarters · filed 2016-03-09 | -$7.13M derived: sum of 3 quarters · filed 2016-03-09 | -$9.25M 10-K · filed 2016-03-09 | |||||||||||||||
| 2014-09-30 | -$2.42M 10-Q · filed 2015-11-16 | -$4.41M derived: sum of 2 quarters · filed 2015-11-16 | -$6.52M 10-Q · filed 2015-11-16 | -$7.73M derived: sum of 4 quarters · filed 2015-11-16 | |||||||||||||||
| 2014-06-30 | -$1.98M 10-Q · filed 2015-08-13 | -$4.09M 10-Q · filed 2015-08-13 | -$5.31M derived: sum of 3 quarters · filed 2015-08-13 | -$6.39M derived: sum of 4 quarters · filed 2015-08-13 | |||||||||||||||
| 2014-03-31 | -$2.11M 10-Q · filed 2015-05-14 | -$3.33M derived: sum of 2 quarters · filed 2015-08-13 | -$4.41M derived: sum of 3 quarters · filed 2015-08-13 | -$5.93M derived: sum of 4 quarters · filed 2015-08-13 | -$54.52M 10-Q · filed 2014-05-13 | ||||||||||||||
| 2013-12-31 | -$1.22M derived: 10-Q 12 month − 10-Q 9 month · filed 2015-08-13 | -$2.30M derived: sum of 2 quarters · filed 2015-08-13 | -$3.82M derived: sum of 3 quarters · filed 2015-08-13 | -$4.90M 10-Q · filed 2015-08-13 | -$52.41M 10-K · filed 2014-03-27 | ||||||||||||||
| 2013-09-30 | -$1.08M 10-Q · filed 2014-11-13 | -$2.60M derived: sum of 2 quarters · filed 2014-11-13 | -$3.68M 10-Q · filed 2014-11-13 | -$4.26M derived: sum of 4 quarters · filed 2014-11-13 | -$51.19M 10-Q · filed 2013-11-14 | ||||||||||||||
| 2013-06-30 | -$1.52M 10-Q · filed 2014-08-12 | -$2.60M 10-Q · filed 2014-08-12 | -$3.18M derived: sum of 3 quarters · filed 2014-08-12 | -$4.33M derived: sum of 4 quarters · filed 2014-08-12 | -$50.11M 10-Q · filed 2013-08-14 | ||||||||||||||
| 2013-03-31 | -$1.08M 10-Q · filed 2014-05-13 | -$1.66M derived: sum of 2 quarters · filed 2014-05-13 | -$2.81M derived: sum of 3 quarters · filed 2014-05-13 | -$3.64M derived: sum of 4 quarters · filed 2014-05-13 | -$48.59M 10-Q · filed 2013-05-09 | ||||||||||||||
| 2012-12-31 | -$579.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-13 | -$1.73M derived: sum of 2 quarters · filed 2014-05-13 | -$2.56M derived: sum of 3 quarters · filed 2014-05-13 | -$3.43M 10-Q · filed 2014-05-13 | -$47.51M 10-K · filed 2013-03-14 | ||||||||||||||
| 2012-09-30 | -$1.15M 10-Q · filed 2013-11-14 | -$1.98M derived: sum of 2 quarters · filed 2013-11-14 | -$2.85M 10-Q · filed 2013-11-14 | -$4.27M derived: sum of 4 quarters · filed 2014-05-13 | -$46.93M 10-Q · filed 2012-11-13 | ||||||||||||||
| 2012-06-30 | -$830.00K 10-Q · filed 2013-08-14 | $830.00K 10-Q/A · filed 2012-08-29 | -$1.70M 10-Q · filed 2013-08-14 | $1.70M 10-Q/A · filed 2012-08-29 | -$3.12M derived: sum of 3 quarters · filed 2014-05-13 | -$3.82M derived: sum of 4 quarters · filed 2014-05-13 | $45.78M 10-Q/A · filed 2012-08-29 | ||||||||||||
| 2012-03-31 | -$872.00K 10-Q · filed 2013-05-09 | -$2.29M derived: sum of 2 quarters · filed 2014-05-13 | -$2.99M derived: sum of 3 quarters · filed 2014-05-13 | -$1.89M derived: sum of 4 quarters · filed 2014-05-13 | -$44.95M 10-Q · filed 2012-05-11 | ||||||||||||||
| 2011-12-31 | -$1.42M derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-13 | -$2.12M derived: sum of 2 quarters · filed 2014-05-13 | -$1.02M derived: sum of 3 quarters · filed 2014-05-13 | -$3.92M 10-Q · filed 2014-05-13 | -$44.08M 10-K · filed 2012-03-15 | ||||||||||||||
| 2011-09-30 | -$694.00K 10-Q · filed 2012-11-13 | $694.00K 10-Q · filed 2011-11-14 | $403.00K derived: sum of 2 quarters · filed 2012-11-13 | -$2.50M 10-Q · filed 2012-11-13 | $2.50M 10-Q · filed 2011-11-14 | -$4.65M derived: sum of 4 quarters · filed 2014-05-13 | $42.66M 10-Q · filed 2011-11-14 | ||||||||||||
| 2011-06-30 | $1.10M 10-Q/A · filed 2012-08-29 | $1.80M 10-Q/A · filed 2012-08-29 | -$3.96M derived: sum of 3 quarters · filed 2014-05-13 | -$3.26M derived: sum of 4 quarters · filed 2014-05-13 | $41.96M 10-Q/A · filed 2011-09-07 | ||||||||||||||
| 2011-03-31 | -$705.00K 10-Q · filed 2012-05-11 | -$5.06M derived: sum of 2 quarters · filed 2014-05-13 | -$4.35M derived: sum of 3 quarters · filed 2014-05-13 | -$3.74M derived: sum of 4 quarters · filed 2014-05-13 | |||||||||||||||
| 2010-12-31 | -$4.35M derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-13 | -$3.65M derived: sum of 2 quarters · filed 2014-05-13 | -$3.03M derived: sum of 3 quarters · filed 2014-05-13 | -$2.42M 10-Q · filed 2014-05-13 | |||||||||||||||
| 2010-09-30 | $704.00K 10-Q · filed 2011-11-14 | $1.32M derived: sum of 2 quarters · filed 2011-11-14 | $1.93M 10-Q · filed 2011-11-14 | ||||||||||||||||
| 2010-06-30 | $614.00K 10-Q/A · filed 2011-09-07 | $1.23M 10-Q/A · filed 2011-09-07 | |||||||||||||||||
| 2009-12-31 | -$1.78M 10-Q · filed 2014-05-13 | ||||||||||||||||||
| 2008-12-31 | -$3.47M 10-Q · filed 2014-05-13 | ||||||||||||||||||
| 2007-12-31 | -$6.24M 10-Q · filed 2014-05-13 | ||||||||||||||||||
| 2006-12-31 | -$3.92M 10-Q · filed 2014-05-13 | ||||||||||||||||||
| 2006-03-31 | -$3.32M 10-Q · filed 2014-05-13 | ||||||||||||||||||
| 2005-03-31 | -$18.84M 10-Q · filed 2014-05-13 | ||||||||||||||||||
| 2004-03-31 | -$73.00K 10-Q · filed 2014-05-13 | ||||||||||||||||||
| 2003-03-31 | -$47.00K 10-Q · filed 2014-05-13 | ||||||||||||||||||
| 2002-03-31 | -$26.00K 10-Q · filed 2014-05-13 | ||||||||||||||||||
| 2001-03-31 | -$17.00K 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |